Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from a seed or nut
Reexamination Certificate
2006-04-18
2006-04-18
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from a seed or nut
C424S725000, C514S002600
Reexamination Certificate
active
07029713
ABSTRACT:
The invention concerns a peptide extract of lupine (lupinus) characterised in that it has a metalloprotease inhibiting activity, in particular collagenase and gelatinase. The invention also concerns a pharmaceutical, cosmetic or nutritional composition comprising a peptide extract, optionally an inert carrier, in particular for treating humans or mammals suffering from a condition or disease related to excessive degeneration of support by a metalloprotease.
REFERENCES:
patent: 2051017 (1936-08-01), Schwarz et al.
patent: 4994272 (1991-02-01), Hussmann et al.
patent: 6039962 (2000-03-01), Cauwet-Martin et al.
patent: 6146616 (2000-11-01), Msika et al.
patent: 6630163 (2003-10-01), Murad
patent: 6703490 (2004-03-01), Perrier et al.
patent: 19640992 (1997-04-01), None
patent: 2778565 (1999-11-01), None
patent: 10007518 (1998-01-01), None
patent: 2000026272 (2000-01-01), None
Publication entitled “Croda launches plant complexes”, Manuafacturing Chemist, Jun. 1998, p. 41, PROMT Abstract enclosed.
Sutherland et al., “Effect of Root Extracts of Resistant Pasture Plants on the Feeding and Survival of Black Beetle Larvae,Heteronychus arator,”New Zealand Journal of Zoology, 5(1), pp. 173-176, 1978. Published by Crown Publishers.
Ballester et al., “Chemical Composition, Nutritive Value, and Toxicological Evaluation of Two Species of Sweet Lupine (Lupinus Albus and Lupinus Luteus).,” J Agric Food Chem 28 (2): pp. 402-405, 1980.
Hines, M., et al., “Screening for Cysteine Proteinase Inhibitor Activity in Legume Seeds.”Journal of the Science of Food and Agriculture, (59) pp. 555-557, Elsevier Applied Science Publishers, Barking, Great Britain, 1992.
Gulewicz et al., “Gibberellic Acid Production byFusarium moniliformeon Lupin Seed Extract” Acta Microbiologica Polonica, 43 (1) pp. 73-77, 1994. Published in Warsaw, Poland.
Silva, et al., “Efeito Inseticida de Extratos Vegetais Sobre Lagartas de Ascia Monuste Orseis” Ciencia e Pratica vol. 19, No. 4, pp. 420-424, 1995. Published by Agropecuario Elaborados.
Wink, et al., “Patterns of Quinolizidine Alkaloids in 56 Species of the Genus Lupinus,” J Phytochem (38) No. 1, pp. 139-153, 1995. Published by Elsevier Science Ltd.
Radlowski, M. et al., “Systemin-an Inducer of Proteinase Inhibitor Synthesis can be Responsible for Biological Activity of Luppin Extract Against Insects.”Journal of Plant Physiology(150): pp. 220-223, Fischer, Stuttgard, Germany, 1997.
Aniszewski et al., “Equilibrium Between Basic Nitrogen Compounds in Lupin Seeds with Differentiated Alkaloid Content.” Phytochemistry 57(1): pp. 43-50, 2001.
Pothier et al., “A Comparative Study of the Effects of Sparteine, Lupanine and Lupin Extract on the Central Nervous System of the Mouse,” Journal of Pharmacy and Pharmacology 50(8) pp. 949-954, 1998. Published by The Royal Pharmaceutical Society of Great Britain.
Msika Philippe
Paul François
Piccirilli Antoine
Foley & Lardner LLP
Laboratoires Pharmascience
Tate Christopher R.
LandOfFree
Peptide extract of lupine and pharmaceutical or cosmetic or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide extract of lupine and pharmaceutical or cosmetic or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide extract of lupine and pharmaceutical or cosmetic or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3555033